Skip to main content
TipRanks
Go Ultimate75% OFF

Pasithea Therapeutics Corp (KTTA) Stock Statistics & Valuation Metrics

153 Followers

Total Valuation

Pasithea Therapeutics Corp has a market cap or net worth of $17.59M. The enterprise value is -$46.66T.

Market Cap
$17.59M
Enterprise Value
-$46.66T

Share Statistics

Pasithea Therapeutics Corp has 36,752,550 shares outstanding. The number of shares has decreased by 5.55% in one year.

Shares Outstanding
36,752,550
Owned by Insiders
15.99%
Owned by Institutions
27.29%

Financial Efficiency

Pasithea Therapeutics Corp’s return on equity (ROE) is -0.37 and return on invested capital (ROIC) is -37.74%.

Return on Equity (ROE)
-0.37
Return on Assets (ROA)
-0.34
Return on Invested Capital (ROIC)
-37.74%
Return on Capital Employed (ROCE)
-0.38
Revenue Per Employee
0
Profits Per Employee
-4.09M
Employee Count
5
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Pasithea Therapeutics Corp is -0.16. Pasithea Therapeutics Corp’s PEG ratio is -0.00.

PE Ratio
-0.16
PS Ratio
0.00
PB Ratio
0.00
Price to FCF
-0.00
Price to Operating Cash Flow
-0.00
PEG Ratio
-0.00

Income Statement

In its last fiscal year, Pasithea Therapeutics Corp had revenue of 0 and earned -20.43M in profits. Earnings per share was -2.91.

Revenue
0
Gross Profit
0
Operating Income
-20.86M
Pretax Income
-20.43M
Net Income
-20.43M
EBITDA
-20.19M
Earnings Per Share (EPS)
-2.91

Cash Flow

In the last 12 months, operating cash flow was -13.98B and capital expenditures 0, giving a free cash flow of -13.98B.

Operating Cash Flow
-13.98B
Free Cash Flow
-13.98B
Free Cash Flow per Share
-1988.85

Dividends & Yields

Pasithea Therapeutics Corp pays an annual dividend of ―, resulting in a dividend yield of ―.

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-79481.73%
Earnings Yield
-737.83%

Stock Price Statistics

Beta
3.72
52-Week Price Change
15.18%
50-Day Moving Average
0.47
200-Day Moving Average
0.60
Relative Strength Index (RSI)
49.79
Average Volume (3m)
705.15K

Important Dates

Pasithea Therapeutics Corp upcoming earnings date is ―, After Close (Confirmed).

Last Earnings Date
Mar 30, 2022
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

Pasithea Therapeutics Corp has a current ratio of 11.35, with a Debt / Equity ratio of 0.00%.

Current Ratio
11.35
Quick Ratio
11.35
Debt to Market Cap
0.00
Net Debt to EBITDA
2.73
Interest Coverage Ratio
0.00

Taxes

In its last fiscal year, Pasithea Therapeutics Corp paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Pasithea Therapeutics Corp EV to EBITDA ratio is 1515.54, with an EV/FCF ratio of 2.95.

EV to Sales
0.00
EV to EBITDA
1515.54
EV to Free Cash Flow
2.95
EV to Operating Cash Flow
2.95

Balance Sheet

Pasithea Therapeutics Corp has $41.22B in cash and marketable securities with $0.00 in debt, giving a net cash position of $41.22B.

Cash & Marketable Securities
$41.22B
Total Debt
$0.00
Net Cash
$41.22B
Net Cash Per Share
$1,121.51
Tangible Book Value Per Share
$5,749.72

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Pasithea Therapeutics Corp is $4.00, which is 736.82% higher than the current price. The consensus rating is Moderate Buy.

Price Target
$4.00
Price Target Upside
736.82% Upside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
―
EPS Growth Forecast
73.07%